Semaglutide reduces sugar production in the liver, delays stomach emptying by slowing intestinal motility, and stimulates insulin secretion. Research has found the medication "semaglutide promotes weight loss via appetite and hunger suppression, decreases energy intake, controls eating, and depresses the relative fondness for fatty, energy-dense foods" (Alorfi & Algarni, 2022, p. 61). Do you want to find out if you're a candidate for semaglutide? Contact me today.
Alorfi, N. M., & Algarni, A. S. (2022). Clinical Impact of Semaglutide, a Glucagon-Like Peptide-1 Receptor Agonist, on Obesity Management: A Review. Clinical pharmacology: advances and applications, 14, 61–67. https://doi.org/10.2147/CPAA.S374741